Overview

Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
Objectives/Purpose: To determine the safety and efficacy of a Vitamin K (Vit K) antagonist (warfarin) in treating Metachromatic Leukodystrophy (MLD).
Phase:
N/A
Details
Lead Sponsor:
The Cooper Health System
Treatments:
Warfarin